Biotech firm CytoMed Therapeutics has priced its shares at $4 each in an IPO in the US while NusaTrip, a unit of Nasdaq-listed Society Pass, has acquired VLeisure in Vietnam.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
